Showing results (81-90 of 121) with videos related to
Sort By:
Pageof 13
The Oncologist|June 28, 2021
Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food IntakeAnna Ozaki, Takaomi Kessoku, Yuki Kasai, et al.Bioscience of Microbiota, Food and Health|April 2, 2024
Efficacy and safety of rifaximin in patients with chronic intestinal pseudo-obstruction: a randomized, double-blind, placebo-controlled, phase II-a exploratory trialHidenori Ohkubo, Takaomi Kessoku, Kosuke Tanaka, et al.Hepato-Gastroenterology|April 29, 2015
Early effects of oral administration of esomeprazole and omeprazole on the intragastric pHHiroshi Iida, Masahiko Inamori, Kotone Okuno, et al.Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|February 2, 2013
Factors predicting the presence of small bowel lesions in patients with obscure gastrointestinal bleedingEiji Sakai, Hiroki Endo, Leo Taniguchi, et al.Digestive Diseases and Sciences|November 28, 2017
Continued Use of a Single Antiplatelet Agent Does Not Increase the Risk of Delayed Bleeding After Colorectal Endoscopic Submucosal DissectionJun Arimoto, Takuma Higurashi, Hideyuki Chiba, et al.Gastrointestinal Endoscopy|May 17, 2014
Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: data from a prospective multicenter capsule endoscopy registryHiroki Endo, Eiji Sakai, Leo Taniguchi, et al.World Journal of Gastroenterology|September 13, 2012
Characteristics of intestinal pseudo-obstruction in patients with mitochondrial diseasesYusuke Sekino, Masahiko Inamori, Eiji Yamada, et al.Scientific Reports|August 10, 2022
A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal diseaseSatsuki Sato, Yohei Kamata, Takaomi Kessoku, et al.Contemporary Clinical Trials|April 9, 2018
Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study designTakaomi Kessoku, Kento Imajo, Takashi Kobayashi, et al.BMC Gastroenterology|November 29, 2014
Frequency and risk factors for rebleeding events in patients with small bowel angioectasiaEiji Sakai, Hiroki Endo, Masataka Taguri, et al.Pageof 13